MAPAX
Price
$31.01
Change
+$0.16 (+0.52%)
Updated
Jul 3 closing price
Net Assets
957.35M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

MAPAX vs VVIAX

Header iconMAPAX vs VVIAX Comparison
Open Charts MAPAX vs VVIAXBanner chart's image
NYLI WMC Value
Price$31.01
Change+$0.16 (+0.52%)
VolumeN/A
Net Assets957.35M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
MAPAX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MAPAX vs. VVIAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAPAX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. MAPAX (957M). VVIAX pays higher dividends than MAPAX: VVIAX (2.18) vs MAPAX (1.39). MAPAX was incepted earlier than VVIAX: MAPAX (26 years) vs VVIAX (25 years). MAPAX (1.02) is less costly to investors than VVIAX (0.05). MAPAX is a more actively managed with annual turnover of: 38.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than MAPAX: VVIAX (3000) vs MAPAX (15000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. MAPAX (8.49). VVIAX return over 5 years is better than : 80.13 vs. MAPAX (-13.45).
MAPAXVVIAXMAPAX / VVIAX
Total Expense Ratio1.020.052,040%
Annual Report Gross Expense Ratio1.020.052,040%
Fund Existence26 years25 years-
Gain YTD5.8006.19894%
Front Load6%N/A-
Min. Initial Investment150003000500%
Min. Initial Investment IRAN/AN/A-
Net Assets957M189B1%
Annual Yield % from dividends1.392.1864%
Returns for 1 year8.4912.0371%
Returns for 3 years19.7135.1756%
Returns for 5 years-13.4580.13-17%
Returns for 10 years-25.46115.67-22%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MYRG188.885.60
+3.06%
MYR Group
BOLT5.920.01
+0.17%
Bolt Biotherapeutics Inc
PGY22.16-0.02
-0.09%
Pagaya Technologies Ltd
OMC74.71-0.31
-0.41%
Omnicom Group
ACTU6.59-0.15
-2.23%
Actuate Therapeutics Inc